Electroporation for Cancer Treatment Real World Registry

Trial Parameters

Brief Summary

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Eligibility Criteria

Inclusion Criteria: * Any patient who has been treated using Calcium Electroporation * Any patient who has been treated using Electrochemotherapy * Patients must be mentally capable of understanding the information given * Patients must give written informed consent. Exclusion Criteria: * None

Related Trials